<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04003480</url>
  </required_header>
  <id_info>
    <org_study_id>CD0177</org_study_id>
    <nct_id>NCT04003480</nct_id>
  </id_info>
  <brief_title>FRAME, External Support for Lower Limb Autologous Grafts</brief_title>
  <official_title>Prospective, Multicenter Study Evaluating the Performance and Safety of FRAME, External Support for Lower Limb Autologous Grafts.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vascular Graft Solutions Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vascular Graft Solutions Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      30 patients will be enrolled in a prospective, multi-center, one-arm study, enrolling
      patients with claudication and chronic limb ischemia scheduled for lower limb venous bypass
      grafting on clinical grounds with single segment autologous saphenous vein.

      Subjects will be followed for 5 years, with follow up visits at 1, 3, 6, 12 months, 2, 3, 4,
      5, years post operation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2020</start_date>
  <completion_date type="Anticipated">September 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary patency</measure>
    <time_frame>12 months</time_frame>
    <description>Freedom of vein graft from occlusion and clinically driven target lesion revascularization as measured by Doppler Ultrasound</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>FRAME</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vein graft to be treated with FRAME</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FRAME</intervention_name>
    <description>External support for vein grafts in peripheral bypass surgery</description>
    <arm_group_label>FRAME</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient scheduled for infrainguinal peripheral artery bypass surgery with single
             segment autogenous saphenous vein.

          2. Rutherford classification 3-6

          3. Adequate revascularization target defined as an infrainguinal arterial segment distal
             to the area of stenosis/occlusion which can support a distal anastomosis of a surgical
             bypass.

          4. Patient is able and willing to give their informed written consent.

          5. Patient is able and willing to comply with study follow up requirements.

          6. Patient is â‰¥ 18 years of age

        Exclusion Criteria:

          1. Patients indicated for endovascular treatment

          2. Prior surgical bypass procedure in ipsilateral lower limb.

          3. Active ulcer/infection/gangrene at the intended distal anastomosis site.

          4. Severe vein varicosity

          5. Saphenous vein with external pressurized diameter of less than 3.5 mm or more than 8
             mm.

          6. Spliced vein technique

          7. In-situ vein technique

          8. Pedal/plantar distal anastomosis

          9. Planned above ankle amputation on ipsilateral limb within 4 weeks of index procedure.

         10. Patients with history of hypercoagulable conditions.

         11. Patients with significant stenoses distal to the planned anastomotic site and any
             other known conditions that could adversely affect graft patency.

         12. Concomitant life-threatening disease likely to limit life expectancy to less than 2
             years.

         13. Contraindication to recommended study medications

         14. Participating in any other investigational study for either drug or device which can
             influence collection of valid data under this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mary Beth Marks, RN, BSN</last_name>
    <phone>212-659-9699</phone>
    <email>mary.marks@mountsinai.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lutheran Hospital of Indiana</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Eichman, RN</last_name>
      <phone>260-458-3579</phone>
      <email>SEichman@Lutheran-Hosp.com</email>
    </contact>
    <investigator>
      <last_name>Vincent Scavo, MD, FACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Freshta Akbari</last_name>
      <phone>410-328-4562</phone>
      <email>fakbari@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Shahab A Toursavadkohi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Bousleiman</last_name>
      <phone>212-241-8250</phone>
      <email>Jamie.Bousleiman@mountsinai.org</email>
    </contact>
    <investigator>
      <last_name>Ageliki G Vouyouka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>June 27, 2019</study_first_submitted>
  <study_first_submitted_qc>June 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2019</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Saphenous vein graft</keyword>
  <keyword>PAD</keyword>
  <keyword>Peripheral bypass surgery</keyword>
  <keyword>external support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

